On 7 November 2022, the Health Sciences Authority (HSA) issued an update on products that were found by overseas regulators to contain potent ingredients. Such potent ingredients are banned from health products as they may cause certain side effects.
- The HSA is not only active in its surveillance in Singapore, but also looks to the actions of regulators in other countries.
- Sellers and suppliers of health products in Singapore should note that anyone who supplies in Singapore health products that are adulterated or counterfeit may face a fine of up to SGD 100,000 and/or imprisonment of up to 3 years.
In more detail
The HSA published a list of products, with images of such products, that were found by overseas regulators to contain potent ingredients, such as sildenafil; paracetamol; piroxicam; mercury; etc.
In the update, the HSA also set out the possible side effects of such potent ingredients, along with an advisory to the public to emphasise caution when dealing with the listed health products and with health products in general.
The overseas regulators range from those in Asia (e.g., Malaysia, Indonesia, Thailand) to Canada and the United States. This shows that the HSA not only surveils health products within Singapore, but also considers the actions of overseas regulators in its enforcement.
The full HSA update may be found here.
* * * * *
© 2022 Baker & McKenzie.Wong & Leow. All rights reserved. Baker & McKenzie.Wong & Leow is incorporated with limited liability and is a member firm of Baker & McKenzie International, a global law firm with member law firms around the world. In accordance with the common terminology used in professional service organizations, reference to a “principal” means a person who is a partner, or equivalent, in such a law firm. Similarly, reference to an “office” means an office of any such law firm. This may qualify as “Attorney Advertising” requiring notice in some jurisdictions. Prior results do not guarantee a similar outcome.